lysophosphatidic acid has been researched along with Cardiovascular Stroke in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, L; Chen, X; Chun, J; Cong, X; Guo, H; Pei, J; Pei, S; Sun, X; Wang, F; Xu, C; Zheng, Z; Zhu, W | 1 |
| Abdel-Latif, A; Abo-Aly, M; Al-Darraji, A; Chelvarajan, L; Gao, E; Hernandez, G; Levitan, BM; Morris, AJ; Peng, H; R Donahue, R; Shokri, E; Smyth, SS; Tripathi, H | 1 |
| Aday, S; Cardoso, C; Carvalheiro, T; Carvalho, L; Duarte, A; Ferreira, L; Fidalgo-Carvalho, I; Gonçalves, L; Grãos, M; Kostic, I; Paiva, A; Vazão, H | 1 |
| Chen, JH; Chen, X; Ding, C; Su, Q; Wang, ND; Yang, XY; Yang, YJ; You, ZJ | 1 |
| Li, JJ; Qu, XF; Song, Y; Xu, DX; Yu, YW; Zhao, J | 1 |
| Cai, Y; Chen, J; Chen, X; Chen, Y; Cong, X; Deng, L; Han, B; Han, Y; Hu, S; Xu, R; Yang, Y; Zhu, W | 1 |
6 other study(ies) available for lysophosphatidic acid and Cardiovascular Stroke
| Article | Year |
|---|---|
LPA
Topics: Animals; Cicatrix; Endothelial Cells; Endothelium, Vascular; Homeostasis; Humans; Lysophospholipids; Mice; Mice, Knockout; Myocardial Infarction; Phosphatidylinositol 3-Kinases; Receptors, Lysophosphatidic Acid; Ventricular Remodeling | 2022 |
Autotaxin inhibition reduces cardiac inflammation and mitigates adverse cardiac remodeling after myocardial infarction.
Topics: Animals; Benzoxazoles; Cell Count; Cell Movement; Female; Gene Deletion; Humans; Inflammation; Interferon-alpha; Interferon-beta; Lysophospholipids; Macrophages; Male; Mice, Inbred C57BL; Middle Aged; Myelopoiesis; Myocardial Infarction; Myocardium; Phosphatidate Phosphatase; Phosphoric Diester Hydrolases; Piperazines; Recovery of Function; Up-Regulation; Vascular Remodeling; Wound Healing | 2020 |
Lysophosphatidic acid enhances survival of human CD34(+) cells in ischemic conditions.
Topics: Animals; Antigens, CD34; Apoptosis; bcl-2-Associated X Protein; Caspase 9; Cell Differentiation; Cell Hypoxia; Cell Proliferation; Cell Survival; Cells, Cultured; Cord Blood Stem Cell Transplantation; Cytokines; Disease Models, Animal; Fetal Blood; Hematopoietic Stem Cells; Humans; Ischemia; Lysophospholipids; Male; Myocardial Infarction; PPAR gamma; Rats; Signal Transduction; Treatment Outcome | 2015 |
Serum lysophosphatidic acid concentrations measured by dot immunogold filtration assay in patients with acute myocardial infarction.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibodies; Antibody Specificity; Binding, Competitive; Biomarkers; Creatine Kinase; Female; Humans; Immunoassay; Isoenzymes; L-Lactate Dehydrogenase; Lysophospholipids; Male; Middle Aged; Myocardial Infarction; Time Factors; Troponin T | 2003 |
[The relationship between the levels of lysophosphatidic acid and left ventricular remodeling after acute myocardial infarction].
Topics: Aged; Collagen Type III; Female; Humans; Lysophospholipids; Male; Middle Aged; Myocardial Infarction; Ventricular Function, Left; Ventricular Remodeling | 2004 |
Specific LPA receptor subtype mediation of LPA-induced hypertrophy of cardiac myocytes and involvement of Akt and NFkappaB signal pathways.
Topics: Animals; Animals, Newborn; Cell Survival; Cells, Cultured; Diphosphates; Enzyme Inhibitors; Female; Glycerol; Hypertrophy; Lysophospholipids; MAP Kinase Signaling System; Myocardial Infarction; Myocytes, Cardiac; NF-kappa B; Organothiophosphates; Phosphatidic Acids; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Receptors, Lysophosphatidic Acid; Signal Transduction; Ventricular Function, Left; Ventricular Remodeling | 2008 |